ctDNA Response: A Tool for Early Proof-of-Concept in Phase I Drug Development
- Liquid biopsy has become an integral component of early oncology drug development
- CtDNA response offers accelerated insights into drug effect, complementing radiographic response
- Intentional steps are needed to effectively operationalize ctDNA response for accelerated development insights